Effect of procyanidolic oligomers on the permeability of the blood-brain barrier.
Blood-brain barrier (BBB) is the site of regulatory mechanisms which control the exchange of substances between the brain and the blood through the wall of 'true' brain capillaries with tight junctions between endothelial cells. In some pathological situations the permeability of the BBB is increased because of a partial proteolytic degradation of some constituents of the capillary basement lamina. In such cases it is important to restore normal permeability. The effect of procyanidolic oligomers (PCO) on the BBB was investigated in vivo with quantitative morphologic procedures. We also investigated the action of this drug on collagen and basement lamina constituents (Matrigel) in vitro. Collagenase injected in lateral brain ventricles was shown to increase BBB permeability. Per os administration of PCO to rats greatly increased the resistance of brain capillaries to bacterial collagenase, as shown by the inhibition of the diffusion of fluorescein-isothiocyanate-marked dextran particles from the blood-stream into the brain tissues. Calf skin collagen pretreated in vitro with PCO became more resistant to the hydrolytic action of collagenase. Similar, even more intense protective effect was seen when basal lamina constituents containing type IV collagen was incubated with PCO before exposure to pronase. These in vitro effects may partly explain the in vivo protective effect of PCO against the alteration of brain capillaries by i.v. injected bacterial collagenase.
Robert
A M
AM
Laboratoire de recherche ophtalmologique, hôpital de l'Hôtel-Dieu, 1, place du Parvis-Notre-Dame, 75181 Paris, France. instderm@club-internet.fr
Tixier
J M
JM
Robert
L
L
Legeais
J M
JM
Renard
G
G
D000818:Animals; D044946:Biflavonoids; D001812:Blood-Brain Barrier / Q000187:drug effects*; D002199:Capillary Permeability / Q000187:drug effects*; D002200:Capillary Resistance / Q000187:drug effects; D002392:Catechin / Q000494:pharmacology*; D003094:Collagen / Q000378:metabolism; D017364:Collagenases / Q000378:metabolism; D003911:Dextrans / Q000378:metabolism; D004338:Drug Combinations; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives / Q000378:metabolism; D007797:Laminin / Q000378:metabolism; D008297:Male; D044945:Proanthocyanidins; D011402:Pronase / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
D044946:Biflavonoids; D003911:Dextrans; D004338:Drug Combinations; D007797:Laminin; D044945:Proanthocyanidins; D011509:Proteoglycans; C015219:fluorescein isothiocyanate dextran; C059485:matrigel; C017674:procyanidin; D002392:Catechin; D003094:Collagen; D017364:Collagenases; D011402:Pronase; D016650:Fluorescein-5-isothiocyanate